| The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria T Zuberbier, W Aberer, R Asero, AH Abdul Latiff, D Baker, ... Allergy 73 (7), 1393-1414, 2018 | 4075* | 2018 |
| Mast cells can enhance resistance to snake and honeybee venoms M Metz, AM Piliponsky, CC Chen, V Lammel, M Åbrink, G Pejler, M Tsai, ... Science 313 (5786), 526-530, 2006 | 447 | 2006 |
| Control of murine hair follicle regression (catagen) by TGF‐β1 in vivo K Foitzik, G Lindner, S Mueller‐Roever, M Maurer, N Botchkareva, ... The FASEB Journal 14 (5), 752-760, 2000 | 444 | 2000 |
| Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control K Weller, A Groffik, MK Church, T Hawro, K Krause, M Metz, P Martus, ... Journal of Allergy and Clinical Immunology 133 (5), 1365-1372. e6, 2014 | 427 | 2014 |
| The definition, diagnostic testing, and management of chronic inducible urticarias – The EAACI/GA2LEN/EDF/UNEV consensus recommendations 2016 update … M Magerl, S Altrichter, E Borzova, A Giménez‐Arnau, CEH Grattan, ... Allergy 71 (6), 780-802, 2016 | 423 | 2016 |
| Mast cells–key effector cells in immune responses M Metz, M Maurer Trends in immunology 28 (5), 234-241, 2007 | 397 | 2007 |
| Autoimmune chronic spontaneous urticaria: what we know and what we do not know P Kolkhir, MK Church, K Weller, M Metz, O Schmetzer, M Maurer Journal of Allergy and Clinical Immunology 139 (6), 1772-1781. e1, 2017 | 385 | 2017 |
| Mast cells in the promotion and limitation of chronic inflammation M Metz, MA Grimbaldeston, S Nakae, AM Piliponsky, M Tsai, SJ Galli Immunological reviews 217 (1), 304-328, 2007 | 377 | 2007 |
| Mast cells promote homeostasis by limiting endothelin-1-induced toxicity M Maurer, J Wedemeyer, M Metz, AM Piliponsky, K Weller, D Chatterjea, ... Nature 432 (7016), 512-516, 2004 | 364 | 2004 |
| IgE mediated autoallergy against thyroid peroxidase–a novel pathomechanism of chronic spontaneous urticaria? S Altrichter, HJ Peter, D Pisarevskaja, M Metz, P Martus, M Maurer PloS one 6 (4), e14794, 2011 | 347 | 2011 |
| Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis M Metz, T Ohanyan, MK Church, M Maurer Journal of dermatological science 73 (1), 57-62, 2014 | 342 | 2014 |
| Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity P Staubach, A Eckhardt‐Henn, M Dechene, A Vonend, M Metz, M Magerl, ... British Journal of Dermatology 154 (2), 294-298, 2006 | 337 | 2006 |
| Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence M Maurer, M Metz, R Brehler, U Hillen, T Jakob, V Mahler, C Pföhler, ... Journal of allergy and clinical immunology 141 (2), 638-649, 2018 | 296 | 2018 |
| The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria TW Chang, C Chen, CJ Lin, M Metz, MK Church, M Maurer Journal of Allergy and Clinical Immunology 135 (2), 337-342. e2, 2015 | 295 | 2015 |
| What is the physiological function of mast cells? M Maurer, T Theoharides, RD Granstein, SC Bischoff, J Bienenstock, ... Experimental dermatology 12 (6), 886-886, 2003 | 288 | 2003 |
| Development and construct validation of the angioedema quality of life questionnaire K Weller, A Groffik, M Magerl, N Tohme, P Martus, K Krause, M Metz, ... Allergy 67 (10), 1289-1298, 2012 | 283 | 2012 |
| The role and relevance of mast cells in urticaria MK Church, P Kolkhir, M Metz, M Maurer Immunological reviews 282 (1), 232-247, 2018 | 277 | 2018 |
| Ligelizumab for chronic spontaneous urticaria M Maurer, AM Giménez-Arnau, G Sussman, M Metz, DR Baker, A Bauer, ... New England Journal of Medicine 381 (14), 1321-1332, 2019 | 265 | 2019 |
| The definition and diagnostic testing of physical and cholinergic urticarias – EAACI/GA2LEN/EDF/UNEV consensus panel recommendations M Magerl, E Borzova, A Giménez‐Arnau, CEH Grattan, F Lawlor, ... Allergy 64 (12), 1715-1721, 2009 | 250 | 2009 |
| Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria J Gericke, M Metz, T Ohanyan, K Weller, S Altrichter, PS Skov, ... Journal of Allergy and Clinical Immunology 139 (3), 1059-1061. e1, 2017 | 243 | 2017 |